Medical professionals consider the prognosis for early stage prostate cancer very good, with a relative 5-year survival rate of 100 percent, as of 2015, states the American Cancer Society. Additionally, regional stage prostate cancer also has a survival rate of 100 percent.
At stages I and II, or the local stage, when there is no sign of the cancer having spread, delaying treatment or avoiding it entirely is a possibility, explains Mayo Clinic. However, doctors recommend active surveillance with regular blood tests, exams and biopsies until the cancer begins progressing.
Treatments for aggressive prostate cancer include external beam radiation that directs energy through X-rays or protons to the prostate cancer, or brachytherapy, a form of radiation in which radioactive seeds release radiation directly into the prostate tissue, states Mayo Clinic. Since prostate cancer cells depend on testosterone to thrive, some men may receive hormone therapy to stop production of testosterone or hinder testosterone from reaching the prostate cancer. Occasionally, surgery to remove the testicles is necessary to reduce hormone levels. Other medical treatment options include surgery to remove the prostate, cryosurgery to freeze cancer cells, chemotherapy and biological therapy.
There is disagreement among medical organizations concerning prostate cancer screening, explains Mayo Clinic. While some cancer experts recommend men begin screening in their 50s, others advise against screening until symptoms present. Individuals should discuss screening recommendations with their doctors.